Undertreatment of hypertension in community-dwelling older adults
- 1 November 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 17 (11), 1633-1640
- https://doi.org/10.1097/00004872-199917110-00018
Abstract
Objective To define: (1) the prevalence of and (2) factors associated with undertreatment of hypertension in older persons; and (3) the prevalence of specific drug regimens and reasons for their selection. Participants Cross-sectional survey of persons aged ≥ 65 years living in Dicomano, Italy. Main outcome measures Prevalence of untreated and uncontrolled hypertension, both defined on the basis of two blood pressure (BP) cut-off points (≥ 140/90 and ≥ 160/90 mmHg) and of the presence of pharmacological treatment. Predictors of undertreatment were analysed for the higher BP cut-off only. Results Five hundred of 692 (72.3%) and 380/692 (54.9%) participants met the 140/90 and the 160/90 mmHg BP criterion, respectively. Of the latter, 162 (42.6%) were untreated, 119 (31.3%) had uncontrolled and 99 (26.1%) controlled hypertension. Women [odds ratio (OR), 0.4; 95% confidence interval (CI), 0.2–0.7], participants with coronary artery disease (CAD) (OR, 0.2; 95% CI, 0.1–0.6), stroke (OR, 0.3; 95% CI, 0.1–0.7), and preserved cognitive status (Mini Mental State Examination score >21: 0.3; 95% CI, 0.2–0.7) were more frequently treated. Uncontrolled hypertension was less likely in women (OR, 0.5; 95% CI, 0.3–1.0) and CAD patients (OR, 0.3; 95% CI, 0.1–0.7). Angiotensin converting enzyme (ACE)-inhibitors (55%), calcium (Ca)-antagonists (31%) and diuretics (20%) were the drugs most commonly prescribed. ACE-inhibitors were preferred, and diuretics rarely used, in diabetic subjects. Ca-antagonists were used mostly in CAD participants. Conclusions Hypertension is undertreated in the majority of noninstitutionalized older adults, especially in men with impaired cognition and no vascular disease. Drug regimens are mostly based on ACE-inhibitors and Ca-antagonists, as a result of associated clinical conditions, requiring individualized treatment.Keywords
This publication has 42 references indexed in Scilit:
- Inadequate Management of Blood Pressure in a Hypertensive PopulationNew England Journal of Medicine, 1998
- Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trialThe Lancet, 1998
- The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressureArchives of Internal Medicine, 1997
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysisJAMA, 1997
- The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)Archives of Internal Medicine, 1993
- Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.BMJ, 1992
- Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)The Lancet, 1991
- Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research GroupJAMA, 1991
- MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2The Lancet, 1985